Press releases

18 February 2013

Europa declares war on heart failure

The HOMAGE (Heart OMics in AGEing) project, coordinated by the French National Institute of Health and Medical Research (INSERM), has been awarded a grant by the European Commission for a six year period. The project aims to... [more]

13 February 2013

Safer than expected: Viral gene therapy in congenital liver defects

Using viruses as gene vectors for gene therapy of congenital genetic liver defects is much safer than scientists previously believed. This is proved by a joint study by REBIRTH-scientists at the TWINCORE and the Hannover Medical... [more]

22 January 2013

Immune system molecule with hidden talents

Dendritic cells, or DCs for short, perform a vital role for the immune system: They engulf pathogens, break them down into their component parts, and then display the pieces on their surface. This in turn signals other immune... [more]

07 January 2013

6. 'Herrenhäuser Forum' on chances and challenges of Regenerative Medicine

The Cell-Wizards: What is meant by stem cell research? On 7 February 2013, 7 p.m. | Location: Schloss Herrenhausen, Hannover-Herrenhausen [more]

07 January 2013

In New Year Speech, Merkel refers to REBIRTH

Federal Chancellor Dr. Angela Merkel’s visit to the MHH on 27 November has made a high impression on her. On 31 December 2012 Merkel brought up the visit in her New Year Speech. The following is an unofficial translation of the... [more]

27 November 2012

„A very impressive niveau“

On 27 November Federal Chancellor Dr. Angela Merkel visited, in the context of an invitation by the Prime Minister David McAllister, the Hannover Medical School to find out about the successes of the Excellence Initiative. During... [more]

01 November 2012

REBIRTH's second funding period has started

On 1 November the second phase (2012-2017) of the Excellence Initiative by the German federal and state governments has commenced: In the next five years the Cluster of Excellence REBIRTH will receive a funding in a double-digit... [more]

29 October 2012

With full force: REBIRTH researchers cultivate functional human heart tissue

Researchers at the Hannover Medical School (MHH) were able to cultivate functional human heart tissue from stem cells. The team of Professor Dr. Ulrich Martin, head of the Leibniz Research Laboratories for Biotechnology and... [more]

10 October 2012

Clinical study: MHH develops new transport system

A previously innovative product is being developed further: Professor Dr. Axel Haverich, Department Head of Cardiothoracic, Transplantation and Vascular Surgery and his team have now made use of a method for lungs as well, which... [more]

10 October 2012

MHH-Researcher receives Heisenberg-Professorship

assumed starting 1 October 2012 in the Department of Cardiology and Angiology of the Hannover Medical School (MHH). The DFG provides funding, in the context of this programme, for excellent scientists as professors for a timespan... [more]

08 October 2012

REBIRTH congratulates Nobel medicine prize winners

The Nobel Prize in Physiology or Medicine 2012 recognizes two scientists, Sir John B. Gurdon and Shinya Yamanaka, who discovered that mature, specialised cells can be reprogrammed to become immature cells capable of developing... [more]

25 September 2012

Scientists prevent heart failure in mice

Cardiac stress, for example a heart attack or high blood pressure, frequently leads to pathological heart growth and subsequently to heart failure. Two tiny RNA molecules play a key role in this detrimental development in mice,... [more]

18 September 2012

The second round has started: The Voluntary Scientific Year programme has been successful

The new group is here! On 3 September 2012, 60 young adults from the Hannover Medical School (MHH), the Leibniz University of Hannover as well as cooperating institutes began their Voluntary Scientific Year (FWJ). It was just... [more]

12 September 2012

The overestimated noble metal: Silver is not the well-tolerated bacterial killer, it seemed to be

For a long time now silver is used in medicine, due to its antibacterial effect. Professor Dr Stephan Barcikowski’s team of the Center for Nanointegration (CENIDE) at the Universität Duisburg-Essen (UDE) has now discovered that... [more]

25 July 2012

MHH and Rentschler Sign Licensing Agreement for an Innovative Gene Therapy Vector System

The Hannover Medical School (MHH) and Rentschler Biotechnologie GmbH have signed a licensing agreement for the commercialization of a vector system for gene therapy that promises significant therapeutic and economic advantages... [more]

test
This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree